Yonsei University College of Medicine, Severance Hospital, 250 Seongsanno, 120-752, Seoul, Republic of Korea.
Stroke. 2011 Sep;42(9):2425-30. doi: 10.1161/STROKEAHA.111.617381. Epub 2011 Jul 21.
The incidence and risk factors for recurrence after endovascular treatment of intracranial vertebrobasilar dissecting aneurysms (VBDAs) have not been studied. We aimed to evaluate the incidence and risk factors for recurrence after endovascular treatment of VBDAs.
A total of 111 patients (mean age, 45±10 years) underwent endovascular treatment for 119 VBDAs (ruptured/unruptured=73:46). Incidence and risk factors for recurrence were retrospectively evaluated.
Sixty-two VBDAs were treated by a reconstructive technique by using 1 to 3 overlapping stents with or without coiling, and 57 VBDAs were treated by a deconstructive technique by using proximal occlusion or internal trapping at the dissected segment of the parent artery. Follow-up angiography was available for 97 VBDAs (81.5%) in 89 patients at 3 days to 48 months (median, 13 months) after treatment. There were 13 recurrences: 6 had rebleeding but 7 had no rebleeding. All 6 hemorrhagic recurrences had initially presented with a ruptured form. Ten recurrences were confirmed by angiography, but 3 recurrences with rebleeding did not receive follow-up angiography. The rate of post-treatment recurrence did not differ between reconstructive and deconstructive treatments. Involvement of the posterior inferior cerebellar artery origin (odds ratio=8.026; 95% confidence interval, 1.561 to 41.259; P=0.013) was the only independent risk factor for recurrence.
There was a 13% recurrence after endovascular treatment of VBDAs. Posterior inferior cerebellar artery origin involvement was the only independent risk factor for recurrence after endovascular treatment of VBDAs.
颅内椎基底动脉夹层动脉瘤(VBDAs)血管内治疗后复发的发生率和危险因素尚未得到研究。本研究旨在评估血管内治疗 VBDAs 后复发的发生率和危险因素。
共 111 例患者(平均年龄 45±10 岁)接受血管内治疗 119 个 VBDAs(破裂/未破裂=73:46)。回顾性评估复发的发生率和危险因素。
62 个 VBDAs 采用重建技术,使用 1 至 3 个重叠支架,有或无线圈填塞,57 个 VBDAs 采用去结构技术,在母动脉夹层节段近端闭塞或内部夹闭。89 例患者中的 97 个 VBDAs(81.5%)可获得治疗后 3 天至 48 个月(中位数 13 个月)的随访血管造影。13 例复发:6 例再出血,7 例无再出血。所有 6 例出血性复发最初均表现为破裂形式。10 例复发经血管造影证实,但 3 例再出血复发未行随访血管造影。重建治疗与去结构治疗后复发率无差异。小脑后下动脉起源受累(优势比=8.026;95%置信区间,1.561 至 41.259;P=0.013)是复发的唯一独立危险因素。
血管内治疗 VBDAs 后复发率为 13%。小脑后下动脉起源受累是血管内治疗 VBDAs 后复发的唯一独立危险因素。